Related EU-projects

FP7

• CELL-PID
  
  • Title: Advanced cell-based Therapies for the treatment of Primary ImmunoDeficiency. Research area: FP7-HEALTH-2010-1.4-1 Translational research on cell-based immunotherapy. Project start date: [2010-11-01]

• RNAI IN HSC VIA NP
  
  • Title: Delivery of siRNAs to hematopoietic stem cells using nanoparticles Research area: FP7-PEOPLE-2009-RG Marie Curie Action: "Reintegration Grants". Project start date: [2010-01-01]

• TREATPD
  
  • Title: Cell and gene therapy based approaches for treatment of Parkinson's disease: From models to clinics Research area: ERC-SG-LS5 ERC Starting Grant - Neurosciences and neural disorders. Project start date: [2009-11-01]

• INDUVIR
  
  • Title: Improved gene transfer system to iPS cells in mouse Research area: FP7-PEOPLE-2009-RG Marie Curie Action: "Reintegration Grants". Project start date: [2009-10-01]

• IRLVGTMND
  • Title: Improved retrograde lentiviral vectors for gene therapy in motor neuron diseases Research area: ERC-AG-LS7 ERC Advanced Grant - Diagnostic tools, therapies and public health. Project start date: [2009-04-01]

• NEUGENE
  
  • Title: Advanced gene therapy tools for treatment of CNS-specific disorders Research area: HEALTH-2007-1.4-5 Gene therapy tools targeting the central nervous system. Project start date: [2008-10-01]

• EUCLYD
  
  • Title: A European consortium for Lysosomal disorders Research area: HEALTH-2007-2.4.4-1 Natural course and pathophysiology of rare diseases. Project start date: [2008-05-01]

• EATRIS
  
  • Title: The European advanced translational research infrastructure in medicine Research area: INFRA-2007-2.2-01 Preparatory phase for the projects in the 2006 ESFRI Roadmap. Project start date: [2008-01-01]

FP6

Concerted Safety & Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases

Activity area acronym: FP6-LIFESCIHEALTH
Project Reference: 5242
Project Acronym: CONSERT
Action Line: LSH-2003-1.2.4-1 Improved gene delivery systems for the therapy of severe acquired diseases,LSH-2003-1.2.4-2 Gene therapy of inherited diseases
Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-1.2.4-1 Improved gene delivery systems for the therapy of severe acquired diseases,LSH-2003-1.2.4-2 Gene therapy of inherited diseases

European network for the advancement of clinical gene transfer and therapy

Activity area acronym: FP6-LIFESCIHEALTH
Project Reference: 18933
Project Acronym: CLINIGENE
Action Line: LSH-2004-1.2.4-3 Quality and safety standards for clinical gene transfer
Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1.2.4-3 Quality and safety standards for clinical gene transfer

Development and application of transposons and site-specific integration technologies as non-viral gene delivery methods for ex vivo gene-based therapies

Activity area acronym: FP6-LIFESCIHEALTH
Project Reference: 18961
Project Acronym: INTHER
Action Line: LSH-2004-1.2.4-4 Development of new non-viral gene delivery technologies for ex vivo gene-based therapies (especially orientated towards involvement of SMEs)
Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1.2.4-4 Development of new non-viral gene delivery technologies for ex vivo gene-based therapies (especially orientated towards involvement of SMEs)

Combined isolation and stable non-viral transfection of hematopoietic cells- a novel platform technology for ex vivo hematopoietic stem cell gene therapy

Activity area acronym: FP6-LIFESCIHEALTH
Project Reference: 19038
Project Acronym: MAGSELECTOFECTION
Action Line: LSH-2004-1.2.4-4 Development of new non-viral gene delivery technologies for ex vivo gene-based therapies (especially orientated towards involvement of SMEs)
Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1.2.4-4 Development of new non-viral gene delivery technologies for ex vivo gene-based therapies (especially orientated towards involvement of SMEs)